S

Surgalign Holdings Inc
F:RT2

Watchlist Manager
Surgalign Holdings Inc
F:RT2
Watchlist
Price: 3.03 EUR -2.73%
Market Cap: 20.1m EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

RT2 price has not been updated for more than 6 months. This may indicate that the stock has been delisted.
RT2 doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of RT2.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RT2 Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

0.3
P/S
P/S
Price to Sales
0.3
vs History
vs Industry
Median 3Y
0.3
Median 5Y
0.3
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.4
Industry
22.1
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-0.5
Median 5Y
-0.5
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.5
Industry
20.2
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-1.4
Industry
2.2
More Details
0.1
EV/S
EV/S
Enterprise Value to Sales
0.1
vs History
vs Industry
Median 3Y
0.1
Median 5Y
0.1
Industry
2.5
More Details
0.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.3
vs History
vs Industry
Median 3Y
0.3
Median 5Y
0.3
Industry
5.1
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.2
Industry
11.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
-0.2
Industry
16.1
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.3
Industry
14.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.2
Industry
18.1
More Details
0.3
EV/IC
EV/IC
Enterprise Value to IC
0.3
vs History
vs Industry
Median 3Y
0.3
Median 5Y
0.3
Industry
1.9
More Details

Multiples Across Competitors

RT2 Competitors Multiples
Surgalign Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Surgalign Holdings Inc
F:RT2
20.1m EUR 0.3 -0.5 -0.2 -0.2
CH
Alcon AG
SIX:ALC
36B CHF 4.6 40.6 18.6 35.2
JP
Hoya Corp
TSE:7741
6.4T JPY 7.4 31.5 19.5 23.3
DK
Coloplast A/S
CSE:COLO B
138.3B DKK 5 30.4 17.6 20.7
US
Align Technology Inc
NASDAQ:ALGN
14.9B USD 3.7 36.4 17.5 21.5
CH
Ypsomed Holding AG
SIX:YPSN
5.8B CHF 7.7 65.8 31.6 54
UK
ConvaTec Group PLC
LSE:CTEC
5B GBP 3 35.5 208.1 340.5
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.6B CNY 12.1 30.6 26.3 26.3
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.1B USD 3.3 19.9 9.2 10.4
CA
Bausch + Lomb Corp
NYSE:BLCO
5B USD 1 -13.9 17.2 75.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
5B USD 3.6 41.1 19.1 33.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
S
Surgalign Holdings Inc
F:RT2
Average EV/EBITDA: 38.5
Negative Multiple: -0.2 		N/A N/A
CH
Alcon AG
SIX:ALC
18.6
10%
1.9
JP
Hoya Corp
TSE:7741
19.5
9%
2.2
DK
Coloplast A/S
CSE:COLO B
17.6
9%
2
US
Align Technology Inc
NASDAQ:ALGN
17.5
15%
1.2
CH
Ypsomed Holding AG
SIX:YPSN
31.6
N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
208.1
11%
18.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.3
18%
1.5
US
Lantheus Holdings Inc
NASDAQ:LNTH
9.2
21%
0.4
CA
Bausch + Lomb Corp
NYSE:BLCO
17.2
19%
0.9
US
Merit Medical Systems Inc
NASDAQ:MMSI
19.1
12%
1.6

See Also

Summary
RT2 intrinsic value, competitors valuation, and company profile.
DCF Valuation
RT2 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RT2 stock valuation using valuation multiples.
Wall Street Estimates
RT2 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RT2 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 270,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.